1. Home
  2. MNDR vs POAI Comparison

MNDR vs POAI Comparison

Compare MNDR & POAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mobile-health Network Solutions Class A Ordinary Shares

MNDR

Mobile-health Network Solutions Class A Ordinary Shares

HOLD

Current Price

$1.77

Market Cap

6.6M

Sector

N/A

ML Signal

HOLD

Logo Predictive Oncology Inc.

POAI

Predictive Oncology Inc.

HOLD

Current Price

$5.55

Market Cap

6.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MNDR
POAI
Founded
2016
2002
Country
Singapore
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.6M
6.5M
IPO Year
2024
N/A

Fundamental Metrics

Financial Performance
Metric
MNDR
POAI
Price
$1.77
$5.55
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
9.9M
27.4K
Earning Date
10-31-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$7,646,739.00
$1,664,407.00
Revenue This Year
$608,852.40
$486.27
Revenue Next Year
N/A
$65.50
P/E Ratio
N/A
N/A
Revenue Growth
N/A
320.71
52 Week Low
$1.53
$4.76
52 Week High
$40.00
$45.90

Technical Indicators

Market Signals
Indicator
MNDR
POAI
Relative Strength Index (RSI) 44.51 35.22
Support Level $1.85 $5.31
Resistance Level $2.92 $6.00
Average True Range (ATR) 0.55 0.55
MACD -0.05 -0.00
Stochastic Oscillator 6.43 7.16

Price Performance

Historical Comparison
MNDR
POAI

About MNDR Mobile-health Network Solutions Class A Ordinary Shares

Mobile-health Network Solutions is a company engaged in providing telehealth solutions in terms of various matrices, such as the number of patient consultations per day and the ranking of its mobile application. It provides services on its MaNaDr platform, which is accessible via mobile application and website. The MaNaDr platform is a platform designed and created by doctors, for doctors and users, equipped with services like consultations with doctors, e-commerce pharma store, and others. The company's operating segments are Telemedicine and other services, and the Sale of medicine and medical devices. The majority of the company's revenue is derived from the Telemedicine and other services segment. Geographically, it derives revenue from Singapore.

About POAI Predictive Oncology Inc.

Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.

Share on Social Networks: